Skip to main content

Assessment of ARIA Sufficiency: Opzelura (ruxolitinib)

    Basic Details
    Approval Date
    Tuesday, September 21, 2021
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes